Humana (HUM) Financials & Stock Analysis

Humana

NYSE: HUM · USD

Revenue

USD millions

$40,867M

Humana Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Revenue
FY 2009 Q2	$7,898.889M; Change unavailable vs FY 2009 Q1
FY 2009 Q3	$7,716.819M; −2.3% vs FY 2009 Q2
FY 2009 Q4	$7,633.045M; −1.1% vs FY 2009 Q3
FY 2010 Q1	$8,440.594M; +10.6% vs FY 2009 Q4
FY 2010 Q2	$8,652.721M; +2.5% vs FY 2010 Q1
FY 2010 Q3	$8,424.648M; −2.6% vs FY 2010 Q2
FY 2010 Q4	$8,350.245M; −0.9% vs FY 2010 Q3
FY 2011 Q1	$9,190.718M; +10.1% vs FY 2010 Q4
FY 2011 Q2	$9,284.131M; +1.0% vs FY 2011 Q1
FY 2011 Q3	$9,300.643M; +0.2% vs FY 2011 Q2
FY 2011 Q4	$9,056M; −2.6% vs FY 2011 Q3
FY 2012 Q1	$10,219M; +12.8% vs FY 2011 Q4
FY 2012 Q2	$9,699M; −5.1% vs FY 2012 Q1
FY 2012 Q3	$9,651M; −0.5% vs FY 2012 Q2
FY 2012 Q4	$9,557M; −1.0% vs FY 2012 Q3
FY 2013 Q1	$10,486M; +9.7% vs FY 2012 Q4
FY 2013 Q2	$10,321M; −1.6% vs FY 2013 Q1
FY 2013 Q3	$10,226M; −0.9% vs FY 2013 Q2
FY 2013 Q4	$10,187M; −0.4% vs FY 2013 Q3
FY 2014 Q1	$11,621M; +14.1% vs FY 2013 Q4
FY 2014 Q2	$12,130M; +4.4% vs FY 2014 Q1
FY 2014 Q3	$12,143M; +0.1% vs FY 2014 Q2
FY 2014 Q4	$12,328M; +1.5% vs FY 2014 Q3
FY 2015 Q1	$13,738M; +11.4% vs FY 2014 Q4
FY 2015 Q2	$13,619M; −0.9% vs FY 2015 Q1
FY 2015 Q3	$13,233M; −2.8% vs FY 2015 Q2
FY 2015 Q4	$13,361M; +1.0% vs FY 2015 Q3
FY 2016 Q1	$13,700M; +2.5% vs FY 2015 Q4
FY 2016 Q2	$13,912M; +1.5% vs FY 2016 Q1
FY 2016 Q3	$13,598M; −2.3% vs FY 2016 Q2
FY 2016 Q4	$12,878M; −5.3% vs FY 2016 Q3
FY 2017 Q1	$13,651M; +6.0% vs FY 2016 Q4
FY 2017 Q2	$13,433M; −1.6% vs FY 2017 Q1
FY 2017 Q3	$13,178M; −1.9% vs FY 2017 Q2
FY 2017 Q4	$13,189M; +0.1% vs FY 2017 Q3
FY 2018 Q1	$14,138M; +7.2% vs FY 2017 Q4
FY 2018 Q2	$14,259M; +0.9% vs FY 2018 Q1
FY 2018 Q3	$14,206M; −0.4% vs FY 2018 Q2
FY 2018 Q4	$14,168M; −0.3% vs FY 2018 Q3
FY 2019 Q1	$16,107M; +13.7% vs FY 2018 Q4
FY 2019 Q2	$16,245M; +0.9% vs FY 2019 Q1
FY 2019 Q3	$16,241M; 0.0% vs FY 2019 Q2
FY 2019 Q4	$16,295M; +0.3% vs FY 2019 Q3
FY 2020 Q1	$18,935M; +16.2% vs FY 2019 Q4
FY 2020 Q2	$19,083M; +0.8% vs FY 2020 Q1
FY 2020 Q3	$20,075M; +5.2% vs FY 2020 Q2
FY 2020 Q4	$19,062M; −5.0% vs FY 2020 Q3
FY 2021 Q1	$20,668M; +8.4% vs FY 2020 Q4
FY 2021 Q2	$20,645M; −0.1% vs FY 2021 Q1
FY 2021 Q3	$20,697M; +0.3% vs FY 2021 Q2
FY 2021 Q4	$21,054M; +1.7% vs FY 2021 Q3
FY 2022 Q1	$23,970M; +13.9% vs FY 2021 Q4
FY 2022 Q2	$23,662M; −1.3% vs FY 2022 Q1
FY 2022 Q3	$22,799M; −3.6% vs FY 2022 Q2
FY 2022 Q4	$22,439M; −1.6% vs FY 2022 Q3
FY 2023 Q1	$26,742M; +19.2% vs FY 2022 Q4
FY 2023 Q2	$26,747M; 0.0% vs FY 2023 Q1
FY 2023 Q3	$26,423M; −1.2% vs FY 2023 Q2
FY 2023 Q4	$26,462M; +0.1% vs FY 2023 Q3
FY 2024 Q1	$29,611M; +11.9% vs FY 2023 Q4
FY 2024 Q2	$29,540M; −0.2% vs FY 2024 Q1
FY 2024 Q3	$29,397M; −0.5% vs FY 2024 Q2
FY 2024 Q4	$29,213M; −0.6% vs FY 2024 Q3
FY 2025 Q1	$32,112M; +9.9% vs FY 2024 Q4
FY 2025 Q2	$32,388M; +0.9% vs FY 2025 Q1
FY 2025 Q3	$32,649M; +0.8% vs FY 2025 Q2
FY 2025 Q4	$32,515M; −0.4% vs FY 2025 Q3
FY 2026 Q1	$39,648M; +21.9% vs FY 2025 Q4
FY 2026 Q2	$40,867M; +3.1% vs FY 2026 Q1

Net income

USD millions

$694M

Humana Net income. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Net income
FY 2009 Q2	$281.78M; Change unavailable vs FY 2009 Q1
FY 2009 Q3	$301.519M; +7.0% vs FY 2009 Q2
FY 2009 Q4	$250.659M; −16.9% vs FY 2009 Q3
FY 2010 Q1	$258.768M; +3.2% vs FY 2009 Q4
FY 2010 Q2	$340.076M; +31.4% vs FY 2010 Q1
FY 2010 Q3	$393.221M; +15.6% vs FY 2010 Q2
FY 2010 Q4	$107.325M; −72.7% vs FY 2010 Q3
FY 2011 Q1	$315.176M; +193.7% vs FY 2010 Q4
FY 2011 Q2	$460.287M; +46.0% vs FY 2011 Q1
FY 2011 Q3	$444.76M; −3.4% vs FY 2011 Q2
FY 2011 Q4	$199M; −55.3% vs FY 2011 Q3
FY 2012 Q1	$248M; +24.6% vs FY 2011 Q4
FY 2012 Q2	$356M; +43.5% vs FY 2012 Q1
FY 2012 Q3	$426M; +19.7% vs FY 2012 Q2
FY 2012 Q4	$192M; −54.9% vs FY 2012 Q3
FY 2013 Q1	$473M; +146.4% vs FY 2012 Q4
FY 2013 Q2	$420M; −11.2% vs FY 2013 Q1
FY 2013 Q3	$368M; −12.4% vs FY 2013 Q2
FY 2013 Q4	$-30M; −108.2% vs FY 2013 Q3
FY 2014 Q1	$368M; +1326.7% vs FY 2013 Q4
FY 2014 Q2	$344M; −6.5% vs FY 2014 Q1
FY 2014 Q3	$290M; −15.7% vs FY 2014 Q2
FY 2014 Q4	$145M; −50.0% vs FY 2014 Q3
FY 2015 Q1	$430M; +196.6% vs FY 2014 Q4
FY 2015 Q2	$431M; +0.2% vs FY 2015 Q1
FY 2015 Q3	$314M; −27.1% vs FY 2015 Q2
FY 2015 Q4	$101M; −67.8% vs FY 2015 Q3
FY 2016 Q1	$234M; +131.7% vs FY 2015 Q4
FY 2016 Q2	$311M; +32.9% vs FY 2016 Q1
FY 2016 Q3	$450M; +44.7% vs FY 2016 Q2
FY 2016 Q4	$-401M; −189.1% vs FY 2016 Q3
FY 2017 Q1	$1,115M; +378.1% vs FY 2016 Q4
FY 2017 Q2	$650M; −41.7% vs FY 2017 Q1
FY 2017 Q3	$499M; −23.2% vs FY 2017 Q2
FY 2017 Q4	$184M; −63.1% vs FY 2017 Q3
FY 2018 Q1	$491M; +166.8% vs FY 2017 Q4
FY 2018 Q2	$193M; −60.7% vs FY 2018 Q1
FY 2018 Q3	$644M; +233.7% vs FY 2018 Q2
FY 2018 Q4	$355M; −44.9% vs FY 2018 Q3
FY 2019 Q1	$566M; +59.4% vs FY 2018 Q4
FY 2019 Q2	$940M; +66.1% vs FY 2019 Q1
FY 2019 Q3	$689M; −26.7% vs FY 2019 Q2
FY 2019 Q4	$512M; −25.7% vs FY 2019 Q3
FY 2020 Q1	$473M; −7.6% vs FY 2019 Q4
FY 2020 Q2	$1,828M; +286.5% vs FY 2020 Q1
FY 2020 Q3	$1,340M; −26.7% vs FY 2020 Q2
FY 2020 Q4	$-274M; −120.4% vs FY 2020 Q3
FY 2021 Q1	$828M; +402.2% vs FY 2020 Q4
FY 2021 Q2	$588M; −29.0% vs FY 2021 Q1
FY 2021 Q3	$1,531M; +160.4% vs FY 2021 Q2
FY 2021 Q4	$-14M; −100.9% vs FY 2021 Q3
FY 2022 Q1	$930M; +6742.9% vs FY 2021 Q4
FY 2022 Q2	$696M; −25.2% vs FY 2022 Q1
FY 2022 Q3	$1,195M; +71.7% vs FY 2022 Q2
FY 2022 Q4	$-15M; −101.3% vs FY 2022 Q3
FY 2023 Q1	$1,239M; +8360.0% vs FY 2022 Q4
FY 2023 Q2	$959M; −22.6% vs FY 2023 Q1
FY 2023 Q3	$832M; −13.2% vs FY 2023 Q2
FY 2023 Q4	$-541M; −165.0% vs FY 2023 Q3
FY 2024 Q1	$741M; +237.0% vs FY 2023 Q4
FY 2024 Q2	$679M; −8.4% vs FY 2024 Q1
FY 2024 Q3	$480M; −29.3% vs FY 2024 Q2
FY 2024 Q4	$-693M; −244.4% vs FY 2024 Q3
FY 2025 Q1	$1,244M; +279.5% vs FY 2024 Q4
FY 2025 Q2	$545M; −56.2% vs FY 2025 Q1
FY 2025 Q3	$195M; −64.2% vs FY 2025 Q2
FY 2025 Q4	$-796M; −508.2% vs FY 2025 Q3
FY 2026 Q1	$1,186M; +249.0% vs FY 2025 Q4
FY 2026 Q2	$694M; −41.5% vs FY 2026 Q1

Net margin

1.7%

Humana Net margin. Reported fiscal history.
Fiscal period	%
FY 2009 Q2	3.57%
FY 2009 Q3	3.91%
FY 2009 Q4	3.28%
FY 2010 Q1	3.07%
FY 2010 Q2	3.93%
FY 2010 Q3	4.67%
FY 2010 Q4	1.29%
FY 2011 Q1	3.43%
FY 2011 Q2	4.96%
FY 2011 Q3	4.78%
FY 2011 Q4	2.2%
FY 2012 Q1	2.43%
FY 2012 Q2	3.67%
FY 2012 Q3	4.41%
FY 2012 Q4	2.01%
FY 2013 Q1	4.51%
FY 2013 Q2	4.07%
FY 2013 Q3	3.6%
FY 2013 Q4	-0.29%
FY 2014 Q1	3.17%
FY 2014 Q2	2.84%
FY 2014 Q3	2.39%
FY 2014 Q4	1.18%
FY 2015 Q1	3.13%
FY 2015 Q2	3.16%
FY 2015 Q3	2.37%
FY 2015 Q4	0.76%
FY 2016 Q1	1.71%
FY 2016 Q2	2.24%
FY 2016 Q3	3.31%
FY 2016 Q4	-3.11%
FY 2017 Q1	8.17%
FY 2017 Q2	4.84%
FY 2017 Q3	3.79%
FY 2017 Q4	1.4%
FY 2018 Q1	3.47%
FY 2018 Q2	1.35%
FY 2018 Q3	4.53%
FY 2018 Q4	2.51%
FY 2019 Q1	3.51%
FY 2019 Q2	5.79%
FY 2019 Q3	4.24%
FY 2019 Q4	3.14%
FY 2020 Q1	2.5%
FY 2020 Q2	9.58%
FY 2020 Q3	6.67%
FY 2020 Q4	-1.44%
FY 2021 Q1	4.01%
FY 2021 Q2	2.85%
FY 2021 Q3	7.4%
FY 2021 Q4	-0.07%
FY 2022 Q1	3.88%
FY 2022 Q2	2.94%
FY 2022 Q3	5.24%
FY 2022 Q4	-0.07%
FY 2023 Q1	4.63%
FY 2023 Q2	3.59%
FY 2023 Q3	3.15%
FY 2023 Q4	-2.04%
FY 2024 Q1	2.5%
FY 2024 Q2	2.3%
FY 2024 Q3	1.63%
FY 2024 Q4	-2.37%
FY 2025 Q1	3.87%
FY 2025 Q2	1.68%
FY 2025 Q3	0.6%
FY 2025 Q4	-2.45%
FY 2026 Q1	2.99%
FY 2026 Q2	1.7%

P/E

× · TTM · Daily

37.69×

Humana P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date	× · TTM · Daily	Financials through
2011-02-28	10.01×	2010-12-31
2011-03-31	10.77×	2010-12-31
2011-04-29	11.72×	2010-12-31
2011-05-31	11.81×	2011-03-31
2011-06-30	11.81×	2011-03-31
2011-07-29	10.94×	2011-03-31
2011-08-31	10.32×	2011-06-30
2011-09-30	9.66×	2011-06-30
2011-10-31	11.28×	2011-06-30
2011-11-30	11.13×	2011-09-30
2011-12-30	10.99×	2011-09-30
2012-01-31	11.17×	2011-09-30
2012-02-29	10.17×	2011-12-31
2012-03-30	10.8×	2011-12-31
2012-04-30	9.42×	2011-12-31
2012-05-31	9.38×	2012-03-31
2012-06-29	9.51×	2012-03-31
2012-07-31	7.57×	2012-03-31
2012-08-31	8.61×	2012-03-31
2012-09-28	8.62×	2012-03-31
2012-10-31	9.12×	2012-03-31
2012-11-30	8.04×	2012-03-31
2012-12-31	8.43×	2012-03-31
2013-01-31	9.13×	2012-03-31
2013-02-28	8.98×	2012-12-31
2013-03-28	9.09×	2012-12-31
2013-04-30	9.75×	2012-12-31
2013-05-31	10.62×	2012-12-31
2013-06-28	11.1×	2012-12-31
2013-07-31	12×	2012-12-31
2013-08-30	12.11×	2012-12-31
2013-09-30	12.27×	2012-12-31
2013-10-31	12.12×	2012-12-31
2013-11-29	11.37×	2013-09-30
2013-12-31	11.29×	2013-09-30
2014-01-31	10.64×	2013-09-30
2014-02-28	12.3×	2013-09-30
2014-03-31	12.33×	2013-09-30
2014-04-30	12×	2013-09-30
2014-05-30	17.31×	2014-03-31
2014-06-30	17.77×	2014-03-31
2014-07-31	16.37×	2014-03-31
2014-08-29	17.91×	2014-03-31
2014-09-30	18.13×	2014-03-31
2014-10-31	19.32×	2014-03-31
2014-11-28	19.19×	2014-03-31
2014-12-31	19.98×	2014-03-31
2015-01-30	20.37×	2014-03-31
2015-02-27	22.87×	2014-03-31
2015-03-31	24.77×	2014-03-31
2015-04-30	23.04×	2014-03-31
2015-05-29	29.86×	2014-03-31
2015-06-30	26.61×	2014-03-31
2015-07-31	21.24×	2015-06-30
2015-08-31	21.32×	2015-06-30
2015-09-30	20.88×	2015-06-30
2015-10-30	20.83×	2015-06-30
2015-11-30	19.23×	2015-09-30
2015-12-31	20.35×	2015-09-30
2016-01-29	18.56×	2015-09-30
2016-02-29	20.89×	2015-12-31
2016-03-31	21.59×	2015-12-31
2016-04-29	20.9×	2015-12-31
2016-05-31	24.05×	2016-03-31
2016-06-30	25.08×	2016-03-31
2016-07-29	24.05×	2016-03-31
2016-08-31	28.07×	2016-06-30
2016-09-30	27.79×	2016-06-30
2016-10-31	26.95×	2016-06-30
2016-11-30	29.28×	2016-09-30
2016-12-30	28.09×	2016-09-30
2017-01-31	27.33×	2016-09-30
2017-02-28	29.09×	2016-09-30
2017-03-31	28.38×	2016-09-30
2017-04-28	30.56×	2016-09-30
2017-05-31	23.44×	2017-03-31
2017-06-30	24.29×	2017-03-31
2017-07-31	23.34×	2017-03-31
2017-08-31	20.68×	2017-06-30
2017-09-29	19.56×	2017-06-30
2017-10-31	20.5×	2017-06-30
2017-11-30	20.35×	2017-09-30
2017-12-29	19.36×	2017-09-30
2018-01-31	21.99×	2017-09-30
2018-02-28	15.82×	2017-12-31
2018-03-29	15.65×	2017-12-31
2018-04-30	17.13×	2017-12-31
2018-05-31	22.15×	2018-03-31
2018-06-29	22.65×	2018-03-31
2018-07-31	23.91×	2018-03-31
2018-08-31	33.78×	2018-06-30
2018-09-28	34.32×	2018-06-30
2018-10-31	32.48×	2018-06-30
2018-11-30	30.22×	2018-09-30
2018-12-31	26.28×	2018-09-30
2019-01-31	28.34×	2018-09-30
2019-02-28	26.14×	2018-09-30
2019-03-29	24.4×	2018-09-30
2019-04-30	23.43×	2018-09-30
2019-05-31	22.46×	2018-09-30
2019-06-28	24.33×	2018-09-30
2019-07-31	27.22×	2018-09-30
2019-08-30	25.98×	2018-09-30
2019-09-30	23.45×	2018-09-30
2019-10-31	26.98×	2018-09-30
2019-11-29	31.3×	2018-09-30
2019-12-31	33.62×	2018-09-30
2020-01-31	30.84×	2018-09-30
2020-02-28	15.75×	2019-12-31
2020-03-31	15.47×	2019-12-31
2020-04-30	18.81×	2019-12-31
2020-05-29	20.23×	2019-12-31
2020-06-30	19.1×	2019-12-31
2020-07-31	19.33×	2019-12-31
2020-08-31	20.45×	2019-12-31
2020-09-30	20.39×	2019-12-31
2020-10-30	19.67×	2019-12-31
2020-11-30	12.85×	2020-09-30
2020-12-31	13.16×	2020-09-30
2021-01-29	12.29×	2020-09-30
2021-02-26	15×	2020-12-31
2021-03-31	16.56×	2020-12-31
2021-04-30	15.5×	2021-03-31
2021-05-28	15.23×	2021-03-31
2021-06-30	15.41×	2021-03-31
2021-07-30	22.2×	2021-06-30
2021-08-31	21.13×	2021-06-30
2021-09-30	20.29×	2021-06-30
2021-10-29	24.14×	2021-06-30
2021-11-30	20.3×	2021-09-30
2021-12-31	22.43×	2021-09-30
2022-01-31	18.98×	2021-09-30
2022-02-28	21×	2021-09-30
2022-03-31	21.04×	2021-09-30
2022-04-29	21.5×	2021-09-30
2022-05-31	21.96×	2021-09-30
2022-06-30	22.63×	2021-09-30
2022-07-29	23.31×	2021-09-30
2022-08-31	23.3×	2021-09-30
2022-09-30	23.46×	2021-09-30
2022-10-31	26.99×	2021-09-30
2022-11-30	26.59×	2021-09-30
2022-12-30	24.77×	2021-09-30
2023-01-31	24.74×	2021-09-30
2023-02-28	23.94×	2021-09-30
2023-03-31	23.47×	2021-09-30
2023-04-28	25.65×	2021-09-30
2023-05-31	24.27×	2021-09-30
2023-06-30	21.62×	2021-09-30
2023-07-31	22.09×	2021-09-30
2023-08-31	22.32×	2021-09-30
2023-09-29	23.53×	2021-09-30
2023-10-31	25.32×	2021-09-30
2023-11-30	23.45×	2021-09-30
2023-12-29	22.14×	2021-09-30
2024-01-31	18.28×	2021-09-30
2024-02-29	15.89×	2022-09-30
2024-03-28	15.73×	2022-09-30
2024-04-30	13.71×	2022-09-30
2024-05-31	16.25×	2022-09-30
2024-06-28	16.95×	2022-09-30
2024-07-31	16.41×	2022-09-30
2024-08-30	16.08×	2022-09-30
2024-09-30	14.37×	2022-09-30
2024-10-31	11.7×	2022-09-30
2024-11-29	13.45×	2022-09-30
2024-12-31	11.51×	2022-09-30
2025-01-31	13.3×	2022-09-30
2025-02-28	11.12×	2023-09-30
2025-03-31	10.88×	2023-09-30
2025-04-30	10.78×	2023-09-30
2025-05-30	9.59×	2023-09-30
2025-06-30	10.05×	2023-09-30
2025-07-31	10.28×	2023-09-30
2025-08-29	12.49×	2023-09-30
2025-09-30	10.7×	2023-09-30
2025-10-31	11.44×	2023-09-30
2025-11-28	10.11×	2023-09-30
2025-12-31	10.53×	2023-09-30
2026-01-30	8.03×	2023-09-30
2026-02-27	19.4×	2025-12-31
2026-03-31	17.66×	2025-12-31
2026-04-30	25.25×	2026-03-31
2026-05-29	32.61×	2026-03-31
2026-06-30	42.41×	2026-03-31
2026-07-31	34.46×	2026-06-30
2026-08-31	36.3×	2026-06-30
2026-09-25	37.69×	2026-06-30

ROE

% · Annual / TTM

6.83%

Humana ROE. Reported fiscal history.
Fiscal period	% · Annual / TTM
FY 2009 Q2	—
FY 2009 Q3	—
FY 2009 Q4	—
FY 2010 Q1	—
FY 2010 Q2	19.95%
FY 2010 Q3	19.9%
FY 2010 Q4	17.31%
FY 2011 Q1	17.36%
FY 2011 Q2	18.14%
FY 2011 Q3	17.94%
FY 2011 Q4	18.94%
FY 2012 Q1	17.49%
FY 2012 Q2	15.56%
FY 2012 Q3	14.85%
FY 2012 Q4	14.45%
FY 2013 Q1	16.63%
FY 2013 Q2	16.99%
FY 2013 Q3	15.88%
FY 2013 Q4	13.56%
FY 2014 Q1	11.92%
FY 2014 Q2	10.86%
FY 2014 Q3	9.85%
FY 2014 Q4	12.1%
FY 2015 Q1	12.23%
FY 2015 Q2	12.91%
FY 2015 Q3	12.89%
FY 2015 Q4	12.77%
FY 2016 Q1	10.5%
FY 2016 Q2	9.16%
FY 2016 Q3	10.13%
FY 2016 Q4	5.84%
FY 2017 Q1	14.21%
FY 2017 Q2	16.62%
FY 2017 Q3	16.56%
FY 2017 Q4	23.85%
FY 2018 Q1	17.96%
FY 2018 Q2	12.92%
FY 2018 Q3	13.87%
FY 2018 Q4	16.83%
FY 2019 Q1	16.81%
FY 2019 Q2	22.69%
FY 2019 Q3	22.98%
FY 2019 Q4	24.39%
FY 2020 Q1	22.54%
FY 2020 Q2	26.64%
FY 2020 Q3	30.35%
FY 2020 Q4	26.14%
FY 2021 Q1	28.04%
FY 2021 Q2	16.97%
FY 2021 Q3	—
FY 2021 Q4	19.68%
FY 2022 Q1	—
FY 2022 Q2	—
FY 2022 Q3	—
FY 2022 Q4	17.88%
FY 2023 Q1	—
FY 2023 Q2	—
FY 2023 Q3	—
FY 2023 Q4	15.77%
FY 2024 Q1	12.17%
FY 2024 Q2	10.21%
FY 2024 Q3	7.88%
FY 2024 Q4	7.4%
FY 2025 Q1	10.09%
FY 2025 Q2	9.03%
FY 2025 Q3	7.15%
FY 2025 Q4	6.98%
FY 2026 Q1	6.22%
FY 2026 Q2	6.83%

Capital allocation

% of tracked cash uses

$530M

Humana capital allocation. Quarterly values. Missing values are unavailable.
Period	Capex	Acquisitions	Buybacks	Dividends	Debt repayments	Tracked uses
FY 2009 Q2	100% · $43.555M	0% · $0M	0% · $0M	Unavailable	Unavailable	100% · $43.555M
FY 2009 Q3	94.41% · $39.533M	0.16% · $0.069M	5.42% · $2.271M	Unavailable	Unavailable	100% · $41.873M
FY 2009 Q4	81.29% · $63.315M	0% · $0M	18.71% · $14.571M	Unavailable	Unavailable	100% · $77.886M
FY 2010 Q1	83.58% · $39.028M	0% · $0M	16.42% · $7.67M	Unavailable	Unavailable	100% · $46.698M
FY 2010 Q2	50.25% · $52.399M	1.6% · $1.669M	48.14% · $50.199M	Unavailable	Unavailable	100% · $104.267M
FY 2010 Q3	50.94% · $61.005M	7.06% · $8.451M	42% · $50.301M	Unavailable	Unavailable	100% · $119.757M
FY 2010 Q4	7.83% · $69.87M	92.13% · $822.33M	0.04% · $0.375M	0% · $0M	Unavailable	100% · $892.575M
FY 2011 Q1	42.88% · $70.481M	3.04% · $5M	54.08% · $88.904M	0% · $0M	0% · $0M	100% · $164.385M
FY 2011 Q2	21.23% · $58.7M	2.15% · $5.952M	76.62% · $211.884M	0% · $0M	0% · $0M	100% · $276.536M
FY 2011 Q3	23.42% · $86.745M	0.73% · $2.7M	64.65% · $239.446M	11.2% · $41.494M	0% · $0M	100% · $370.385M
FY 2011 Q4	33.9% · $130.074M	55.34% · $212.348M	0.2% · $0.766M	10.56% · $40.506M	0% · $0M	100% · $383.694M
FY 2012 Q1	23.24% · $86M	15.14% · $56M	40.81% · $151M	11.08% · $41M	9.73% · $36M	100% · $370M
FY 2012 Q2	34.49% · $99M	6.97% · $20M	44.25% · $127M	14.29% · $41M	0% · $0M	100% · $287M
FY 2012 Q3	19.57% · $119M	34.87% · $212M	38.65% · $235M	6.91% · $42M	0% · $0M	100% · $608M
FY 2012 Q4	9.65% · $106M	86.17% · $947M	0.45% · $5M	3.73% · $41M	0% · $0M	100% · $1,099M
FY 2013 Q1	38.96% · $90M	2.16% · $5M	40.69% · $94M	18.18% · $42M	0% · $0M	100% · $231M
FY 2013 Q2	34.4% · $97M	2.48% · $7M	48.58% · $137M	14.54% · $41M	0% · $0M	100% · $282M
FY 2013 Q3	30.15% · $123M	36.52% · $149M	23.04% · $94M	10.29% · $42M	0% · $0M	100% · $408M
FY 2013 Q4	32.27% · $131M	6.4% · $26M	50.74% · $206M	10.59% · $43M	0% · $0M	100% · $406M
FY 2014 Q1	51.71% · $106M	2.93% · $6M	23.9% · $49M	21.46% · $44M	Unavailable	100% · $205M
FY 2014 Q2	43.14% · $110M	Unavailable	40.39% · $103M	16.47% · $42M	Unavailable	100% · $255M
FY 2014 Q3	47.39% · $145M	0% · $0M	38.56% · $118M	14.05% · $43M	Unavailable	100% · $306M
FY 2014 Q4	20.19% · $167M	1.81% · $15M	72.79% · $602M	5.2% · $43M	Unavailable	100% · $827M
FY 2015 Q1	52.79% · $123M	0% · $0M	28.33% · $66M	18.88% · $44M	Unavailable	100% · $233M
FY 2015 Q2	26.1% · $136M	7.29% · $38M	58.54% · $305M	8.06% · $42M	Unavailable	100% · $521M
FY 2015 Q3	70.62% · $125M	0% · $0M	5.08% · $9M	24.29% · $43M	Unavailable	100% · $177M
FY 2015 Q4	74.33% · $139M	0% · $0M	2.67% · $5M	22.99% · $43M	Unavailable	100% · $187M
FY 2016 Q1	51.44% · $125M	0% · $0M	29.22% · $71M	19.34% · $47M	Unavailable	100% · $243M
FY 2016 Q2	74.01% · $131M	0.56% · $1M	1.13% · $2M	24.29% · $43M	Unavailable	100% · $177M
FY 2016 Q3	73.16% · $139M	3.16% · $6M	1.05% · $2M	22.63% · $43M	Unavailable	100% · $190M
FY 2016 Q4	64.39% · $132M	0% · $0M	14.15% · $29M	21.46% · $44M	Unavailable	100% · $205M
FY 2017 Q1	6.97% · $122M	0.4% · $7M	89.94% · $1,574M	2.69% · $47M	Unavailable	100% · $1,750M
FY 2017 Q2	63.79% · $111M	1.15% · $2M	2.3% · $4M	32.76% · $57M	Unavailable	100% · $174M
FY 2017 Q3	32.28% · $143M	0.23% · $1M	54.4% · $241M	13.09% · $58M	Unavailable	100% · $443M
FY 2017 Q4	8.45% · $150M	1.18% · $21M	87.1% · $1,546M	3.27% · $58M	Unavailable	100% · $1,775M
FY 2018 Q1	32.6% · $134M	41.12% · $169M	12.41% · $51M	13.87% · $57M	Unavailable	100% · $411M
FY 2018 Q2	31.8% · $138M	42.63% · $185M	9.68% · $42M	15.9% · $69M	Unavailable	100% · $434M
FY 2018 Q3	37.79% · $164M	0% · $0M	46.31% · $201M	15.9% · $69M	Unavailable	100% · $434M
FY 2018 Q4	16.89% · $176M	0% · $0M	76.39% · $796M	6.72% · $70M	Unavailable	100% · $1,042M
FY 2019 Q1	64.06% · $139M	0% · $0M	4.61% · $10M	31.34% · $68M	Unavailable	100% · $217M
FY 2019 Q2	67.97% · $157M	0% · $0M	0% · $0M	32.03% · $74M	Unavailable	100% · $231M
FY 2019 Q3	16.36% · $210M	0% · $0M	77.88% · $1,000M	5.76% · $74M	Unavailable	100% · $1,284M
FY 2019 Q4	63.01% · $230M	0% · $0M	16.44% · $60M	20.55% · $75M	Unavailable	100% · $365M
FY 2020 Q1	19.37% · $192M	71.54% · $709M	1.72% · $17M	7.37% · $73M	Unavailable	100% · $991M
FY 2020 Q2	71.29% · $226M	0% · $0M	2.52% · $8M	26.18% · $83M	Unavailable	100% · $317M
FY 2020 Q3	73.96% · $250M	0% · $0M	1.48% · $5M	24.56% · $83M	Unavailable	100% · $338M
FY 2020 Q4	13.64% · $296M	0% · $0M	82.49% · $1,790M	3.87% · $84M	Unavailable	100% · $2,170M
FY 2021 Q1	55.13% · $290M	23.38% · $123M	5.7% · $30M	15.78% · $83M	Unavailable	100% · $526M
FY 2021 Q2	52.72% · $329M	32.37% · $202M	0.48% · $3M	14.42% · $90M	Unavailable	100% · $624M
FY 2021 Q3	8.04% · $326M	89.66% · $3,634M	0.07% · $3M	2.22% · $90M	Unavailable	100% · $4,053M
FY 2021 Q4	50.61% · $371M	31.11% · $228M	5.87% · $43M	12.41% · $91M	Unavailable	100% · $733M
FY 2022 Q1	19.88% · $295M	4.99% · $74M	69% · $1,024M	6.13% · $91M	Unavailable	100% · $1,484M
FY 2022 Q2	58.61% · $279M	19.54% · $93M	0.84% · $4M	21.01% · $100M	Unavailable	100% · $476M
FY 2022 Q3	55.6% · $288M	24.32% · $126M	0.77% · $4M	19.31% · $100M	Unavailable	100% · $518M
FY 2022 Q4	17.59% · $258M	3% · $44M	72.53% · $1,064M	6.88% · $101M	Unavailable	100% · $1,467M
FY 2023 Q1	45.51% · $223M	14.9% · $73M	19.18% · $94M	20.41% · $100M	Unavailable	100% · $490M
FY 2023 Q2	25.88% · $264M	11.37% · $116M	51.86% · $529M	10.88% · $111M	Unavailable	100% · $1,020M
FY 2023 Q3	30.95% · $234M	4.5% · $34M	50.13% · $379M	14.42% · $109M	Unavailable	100% · $756M
FY 2023 Q4	29.03% · $283M	1.03% · $10M	58.56% · $571M	11.38% · $111M	Unavailable	100% · $975M
FY 2024 Q1	17.4% · $177M	1.38% · $14M	70.5% · $717M	10.72% · $109M	Unavailable	100% · $1,017M
FY 2024 Q2	41.76% · $114M	1.1% · $3M	17.95% · $49M	39.19% · $107M	Unavailable	100% · $273M
FY 2024 Q3	50.19% · $130M	7.72% · $20M	0.77% · $2M	41.31% · $107M	Unavailable	100% · $259M
FY 2024 Q4	42.42% · $154M	14.33% · $52M	13.5% · $49M	29.75% · $108M	Unavailable	100% · $363M
FY 2025 Q1	44.81% · $95M	0% · $0M	4.25% · $9M	50.94% · $108M	0% · $0M	100% · $212M
FY 2025 Q2	10.44% · $114M	0.09% · $1M	9.16% · $100M	9.71% · $106M	70.6% · $771M	100% · $1,092M
FY 2025 Q3	54.88% · $135M	1.63% · $4M	0% · $0M	43.5% · $107M	Unavailable	100% · $246M
FY 2025 Q4	47.09% · $202M	17.72% · $76M	9.79% · $42M	25.41% · $109M	Unavailable	100% · $429M
FY 2026 Q1	9.63% · $121M	72.53% · $911M	8.52% · $107M	8.52% · $107M	0.8% · $10M	100% · $1,256M
FY 2026 Q2	24.91% · $132M	3.58% · $19M	0.19% · $1M	20.19% · $107M	51.13% · $271M	100% · $530M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Humana.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

Revenue: Reported revenue from company filings.
Net income: Reported company figures.
Net margin: Reported net income / revenue × 100.
P/E: Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROE: Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
Capital allocation: Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.

Reported revenue and sources

Humana financials